Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fengliao Changwei Kang Oral Liquid is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Chongqing Sainuo Biological Pharmaceutical. It is primarily composed of extracts from *Polygonum hydropiper* (Water Pepper) and *Daphne tangutica* (Fengliao). The preparation is indicated for the treatment of gastrointestinal disorders, specifically acute gastroenteritis characterized by damp-heat in the stomach and intestines, manifesting as abdominal pain, diarrhea, and bloating. It functions by clearing heat, resolving dampness, and regulating the stomach and intestines. Pharmacological studies suggest it possesses anti-inflammatory, analgesic, and antibacterial properties, and it is used to restore normal gastrointestinal motility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fengliao changwei kang oral liquid.